000 | 01934 a2200493 4500 | ||
---|---|---|---|
005 | 20250516164603.0 | ||
264 | 0 | _c20140318 | |
008 | 201403s 0 0 eng d | ||
022 | _a1873-3441 | ||
024 | 7 |
_a10.1016/j.ejpb.2013.03.011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGermershaus, Oliver | |
245 | 0 | 0 |
_aInsulin-like growth factor-I aerosol formulations for pulmonary delivery. _h[electronic resource] |
260 |
_bEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V _cSep 2013 |
||
300 |
_a61-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAerosols |
650 | 0 | 4 | _aBuffers |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aChemistry, Pharmaceutical |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 |
_aExcipients _xchemistry |
650 | 0 | 4 |
_aGrowth Substances _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xadministration & dosage |
650 | 0 | 4 | _aNebulizers and Vaporizers |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 | _aProtein Stability |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 |
_aRespiratory System Agents _xadministration & dosage |
650 | 0 | 4 | _aSalinity |
650 | 0 | 4 | _aSolubility |
700 | 1 | _aSchultz, Isabel | |
700 | 1 | _aLühmann, Tessa | |
700 | 1 | _aBeck-Broichsitter, Moritz | |
700 | 1 | _aHögger, Petra | |
700 | 1 | _aMeinel, Lorenz | |
773 | 0 |
_tEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V _gvol. 85 _gno. 1 _gp. 61-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejpb.2013.03.011 _zAvailable from publisher's website |
999 |
_c23016300 _d23016300 |